Takeaway

• Patients with recent stroke and minimal to moderate neurologic deficits have a similar prevalence of clinically significant symptoms of depression whether treated with fluoxetine or placebo.

Why this matters

• Depression is common in this population, but evidence supporting use of antidepressants is limited.
• Editorial notes the possibility that the targeted...